Concussion, Brain Clinical Trial
Official title:
The Effect of Screen Time on Recovery From Concussion
NCT number | NCT03564210 |
Other study ID # | H00014355 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | May 7, 2018 |
Est. completion date | April 1, 2020 |
Verified date | November 2020 |
Source | University of Massachusetts, Worcester |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study will prospectively examine the effect of screen time on recovery from concussion. Patients 12 to 25 years of age presenting to the ED with a concussion will be randomized to allow for screen time as tolerated or to abstain from screen time for the first 48 hours of recovery. The amount of screen time use and duration of concussive symptoms will be assessed through daily surveys and a daily post-concussive symptom score (PCSS).
Status | Completed |
Enrollment | 125 |
Est. completion date | April 1, 2020 |
Est. primary completion date | April 1, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 12 Years to 25 Years |
Eligibility | Inclusion Criteria: - Individuals presenting to the emergency department with a traumatic head injury sustained in the last 24 hours and diagnosed concussion as defined by Acute Concussion Evaluation tool (ACE-ED) - Between 12 and 25.99 years of age - English-speaking - Subject (and parent/guardian when applicable) is able and willing to provide informed consent and assent - pregnant women, Exclusion Criteria: - individuals who have a Glasgow Coma Scale score of 13 or less; - have brain abnormalities on imaging; - have severe preexisting neurological conditions; - a concussion diagnosed within the last 2 weeks; - have significant developmental delay; - are intoxicated; - require neurosurgical intervention, intubation, or hospital admission - individuals who do not meet the age criteria; - non-English speaking; - prisoners; - unable or unwilling to provide informed consent; - Are under the age of 18 and do not have a parent/guardian with them who is willing and able to consent. |
Country | Name | City | State |
---|---|---|---|
United States | UMass Memorial Medical Center | Worcester | Massachusetts |
Lead Sponsor | Collaborator |
---|---|
Theodore Macnow |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Duration of concussive symptoms | The average number of days from initial concussion diagnosis until participant has a Post Concussive Symptom Scale Score (PCSS) of less than 7 | From date of randomization until PCSS of less than 7 is achieved or up to 10 days, whichever comes first. | |
Secondary | Number of specific symptoms (Day 1-3) | The average total number of symptoms as reported on the Post Concussive Symptom Scale (PCSS) by participant. | Day 1 to day 3 | |
Secondary | Number of specific symptoms each day (Day 4-10) | The average total number of symptoms as reported on the Post Concussive Symptom Scale (PCSS) by participant. | Day 4 to day 10 | |
Secondary | Severity of specific symptoms (Day 1-3) | The average severity of symptoms as reported on the Post Concussive Symptom Scale (PCSS) by participant. | Day 1 to day 3 | |
Secondary | Severity of specific symptoms (Day 4-10) | The average severity of symptoms as reported daily by participant on the Post Concussive Symptom Scale (PCSS) by participant. | Day 4 to day 10 | |
Secondary | Amount of screen time use | Average minutes of screen time (video games, television, computer, smartphone) as self-reported by participant on questionnaire. | Randomization to 48 hours. | |
Secondary | Days until return to school/work and sports | The average number of days until the participant is able to return to routine activities such as school/work and sports as self-reported on questionnaire. | From date of randomization to return to school/work and sports, up to day 10. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04109677 -
AIM CONTROL and SWECON - Handball The SWEdish CONcussion Study in Elite Handball
|
||
Recruiting |
NCT04932278 -
The Role of Osteopathic Manipulative Medicine in Recovery From Concussions
|
N/A | |
Withdrawn |
NCT05062148 -
Fundamental and Applied Concussion Recovery Modality Research and Development: Applications for the Enhanced Recovery
|
N/A | |
Recruiting |
NCT05682677 -
Combined Neuromodulation and Cognitive Training for Post-mTBI Depression
|
N/A | |
Recruiting |
NCT04992130 -
Sport Concussion Performance-Based Prevention Program
|
N/A | |
Completed |
NCT05095012 -
RECOVER Clinical Pathway for Pediatric Concussion
|
N/A | |
Recruiting |
NCT05886400 -
The Effects of Environmental Distractions on SCAT6 Outcomes
|
N/A | |
Active, not recruiting |
NCT05400551 -
Craneofacial Injuries in Rink Hockey Athletes
|
||
Recruiting |
NCT04121780 -
Growth Hormone Replacement Therapy for Retried Professional Football Players
|
Phase 2 | |
Withdrawn |
NCT03575741 -
Postural Control in Children and Adolescents After Suffering From a Concussion
|
||
Active, not recruiting |
NCT05471791 -
Development of a Concussion Management Platform for Children and Youth
|
N/A | |
Completed |
NCT04730167 -
The Monaco Initiative for Concussion in Motorsport Pilots
|
||
Completed |
NCT03478059 -
Dual-task Assessment and Rehabilitation for Individuals With Residual Symptoms After mTBI
|
N/A | |
Recruiting |
NCT05685121 -
A Wrist-Worn Nerve Stimulator for Remediating Persistent Post-Concussive Symptoms in Adolescents
|
N/A | |
Completed |
NCT04122274 -
Comparing and Interactive Concussion Education Platform to Current Education Standards
|
N/A | |
Completed |
NCT04558346 -
Ghrelin (OXE--103) for Acute Concussion Management
|
Phase 2 | |
Completed |
NCT04074486 -
Evaluation and Validation of a Multimodal Brain Function Biomarker With NPC
|
||
Not yet recruiting |
NCT05562232 -
The Effect of Creatine Monohydrate on Persistent Post-concussive Symptoms
|
N/A | |
Recruiting |
NCT05326555 -
Dynamic Vision Testing and Concussion Management Dream Team 65
|
||
Completed |
NCT03671083 -
Validation of Brain Function Assessment Algorithm for mTBI/Concussion
|